Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Dubuque, IA MSA — September 2026
Dubuque regulatory and validation pay climb as data roles lag.
Validation Engineer advertised pay hit $121,331 locally—above the $108,377 national figure—while Clinical Data Manager pay fell to $89,187 against a declining $123,031 national median, underscoring how thin local demand distorts role-specific benchmarking in this tight 3.2% unemployment market.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Dubuque unemployment rate: 3.3% — July 2026, vs 4.1% national rate
- Validation Engineer advertised pay: $121,331 — Metro median vs $108,377 national
- Clinical Data Manager advertised pay: $89,187 — Metro median, down significantly vs national $123,031
- Iowa manufacturing job gains: +1,300 — August 2026, state's largest sector gain
Key takeaways
Validation Engineer pay is outpacing the national market here.
Metro median advertised pay of $121,331 sits above the $108,377 national figure and is rising faster locally. Manufacturing-adjacent quality and validation functions appear to be absorbing Iowa's 1,300 new manufacturing jobs in August, tightening competition for device and CDMO validation talent specifically.
Clinical Data Manager pay decline may signal weak local demand.
Metro median fell significantly to $89,187 against a national median of $123,031 that is itself declining moderately. Given limited local biotech R&D concentration, this likely reflects thin posting volume rather than genuine softening—treat local figures cautiously for this role and consider national benchmarks instead.
Regulatory Affairs Specialist pay is rising locally while holding steady nationally.
Metro median climbed significantly to $90,187 even as the national median held flat near $104,000, consistent with national reporting that regulatory affairs talent is in acute global short supply. Any Dubuque-area employer competing for regulatory talent should expect upward pressure independent of national stability.
Research Scientist pay gap with national market may reflect local employer mix.
Metro median of $104,805 trails the national median of $131,354 by roughly 20%, even though both are rising. Iowa's limited biotech R&D footprint beyond Ames and scattered specialty players suggests Dubuque-based research roles may skew toward applied or quality-adjacent work rather than discovery science, a distinction worth confirming before anchoring pay decisions to national research scientist figures.
Median advertised pay by role — Dubuque, IA MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $74,181 | $104,805 | $112,429 | Significant increase | $131,354 |
| Clinical Research Associate * | $57,200 | $106,222 | $125,628 | Significant increase | $90,956 |
| Lab Technician * | $39,439 | $44,656 | $48,378 | Moderate decline | $47,402 |
| Regulatory Affairs Specialist * | $74,639 | $90,187 | $103,011 | Significant increase | $104,000 |
| Clinical Data Manager * | $74,125 | $89,187 | $112,693 | Significant decline | $123,031 |
| Biostatistician * | $86,372 | $110,253 | $146,269 | Moderate decline | $133,322 |
| Validation Engineer * | $118,498 | $121,331 | $123,498 | Significant increase | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Dubuque's labor market remains exceptionally tight, with unemployment near 2.4-3.3% across 2026 readings and non-farm employment holding near record levels around 58,700-62,200, giving workers continued leverage despite 130 John Deere Dubuque Works layoffs earlier this year. Statewide manufacturing added 1,300 jobs in August even as Iowa's workforce shrinks from retirement-driven attrition, a dynamic that intensifies competition for the specialized scientific and technical talent life sciences employers need in a metro with limited captive biotech R&D presence.
What it means
Dubuque's thin life sciences talent base means most specialized roles—research scientists, biostatisticians, regulatory affairs specialists—are effectively priced against regional and national markets rather than a deep local bench, and advertised pay here is moving in surprising directions relative to national trends, with Validation Engineer up significantly locally ($121,331) against moderate national growth, while Clinical Data Manager and Biostatistician pay are falling locally even as national demand for the latter rises. This divergence complicates build-vs-outsource calculus for quality and manufacturing-adjacent functions, since local wage signals may understate true competitive pressure for roles tied to national specialist pools. Organizations should evaluate whether Dubuque-specific postings are capturing enough qualified applicants, or whether functions like clinical data management and biostatistics need remote-eligible postings benchmarked nationally rather than locally to remain competitive for scarce talent.
Looking ahead
Emerging pressure point: Iowa's working-age population continues shrinking from retirement, down 7,500 year-over-year statewide. Watch whether this accelerates departures from manufacturing and quality roles that feed life sciences-adjacent CDMO and device employers in the Dubuque area.
Worth watching: September's national biopharma layoff announcements (BioMarin, Bristol Myers) are concentrated in consolidation functions, not execution-critical roles. Monitor whether any displaced regulatory, quality, or CMC talent becomes available for remote or relocation-eligible Dubuque-area postings.
Potential inflection point: Iowa's new Career Training Physical Expansion Grants, launched September 15, target apprenticeship capacity for mid-skill manufacturing and technician roles. Evaluate whether this creates a near-term pipeline for lab technician and validation support roles currently facing moderate advertised pay declines.
Expected: Official July 2026 BLS metro data (58,700 non-farm employment, 3.3% unemployment) will be followed by September figures in November, with a two-month reporting lag typical for this metro. Budget compensation reviews around that release rather than relying on seasonally volatile interim readings.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.